Skip to content

Massage Impact on Sleep in Pediatric Oncology

Massage Impact on Sleep in Hospitalization for Pediatric Oncology and Stem Cell Transplant Patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06892158
Enrollment
70
Registered
2025-03-24
Start date
2025-01-23
Completion date
2028-07-01
Last updated
2026-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Lymphoblastic Leukemia, Pediatric, Acute Myeloid Leukemia, Cancer, Chemotherapy Effect, Hematopoietic Stem Cell Transplantation (HSCT), Pediatric Cancer

Keywords

Stem cell transplant (SCT), Decreased sleep efficiency, Pediatric cancer diagnosis, Circadian activity rhythm (CAR)

Brief summary

This study aims to determine the impact of massage therapy for pediatric patients receiving intensive chemotherapy or stem cell transplant (SCT).

Detailed description

Hospitalized pediatric oncology patients report anxiety, pain, disturbed sleep, and excess fatigue. Massage is safe, does not interfere with medications, and has been shown in limited studies to have efficacy in improving sleep as well as decreasing fatigue, anxiety and other symptoms in cancer patients and children with various ailments. This project aims to determine if individualized massage therapy for hospitalized pediatric patients receiving intensive chemotherapy or stem cell transplant (SCT) is associated with longer duration and improved quality of sleep, more robust circadian rhythms (CARs), improved quality of life (QOL) and reduced fatigue, anxiety, and pain, as compared to a standard of care group.

Interventions

OTHERMassage therapy

Participants in IA will receive a 20-30-minute massage five days per week for 21 days.

OTHERStandard of care

Institutional standard of care treatment

Sponsors

Children's Hospital of Philadelphia
Lead SponsorOTHER
Massage Therapy Foundation
CollaboratorOTHER
Children's National Research Institute
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

This study is a randomized, two-group design (intervention arm, IA and control arm, CA).

Eligibility

Sex/Gender
ALL
Age
12 Years to 21 Years
Healthy volunteers
No

Inclusion criteria

1. Diagnosis of cancer, such as acute myeloid leukemia (AML) or relapsed acute lymphoblastic leukemia (rALL) OR admitted to receive autologous or allogeneic HSCT for any indication 2. Expected to be an inpatient for at least 21 days 3. Aged 12 to 21 years at enrollment. 4. Inpatient at Children's National or Children's Hospital of Philadelphia (CHOP).

Exclusion criteria

1. Cognitive impairment sufficient to preclude completing questionnaires appropriately 2. Insufficient knowledge of English or Spanish that would prohibit completing the study instruments 3. Previous enrollment

Design outcomes

Primary

MeasureTime frameDescription
Change in total sleep minutes3 weeksChange in the total number of sleep minutes over time in the standard of care intervention compared to the change in the total number of sleep minutes over time in the massage therapy intervention. Sleep minutes are measured by actigraphy.

Secondary

MeasureTime frameDescription
Change in sleep quality as demonstrated by circadian activity rhythms (CARs)3 weeksAmount of dysrgulation in CARs in the standard of care intervention compared to the amount of dysregulation in CARs in the massage therapy intervention. Dysregulation in CARs will be measured by actigraphy (24-h autocorrelation).

Countries

United States

Contacts

CONTACTLauren Vernau
vernaul@chop.edu267-426-1162
PRINCIPAL_INVESTIGATORTracey Jubelirer, MD

Children's Hospital of Philadelphia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 16, 2026